Latest Drug Development Stories
COLORADO SPRINGS, Colo., March 31, 2015 /PRNewswire/ -- Cannabis Science, Inc. (OTCQB: CBIS) today announced it has entered into a one-year agreement with Derwin A.
CUPERTINO, Calif., March 30, 2015 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) today announced that it has initiated a multi-dose Phase 1 clinical trial of an oral formulation of DUR-928,
MUMBAI, March 20, 2015 /PRNewswire/ -- This is first time in history, Chinese pharmaceutical authorities officially issued a guidance on international multi-center clinical
THE REPORT BOASTS STRONG SCIENTIFIC MANAGEMENT AND PARTNERS IN A MEDICAL CANNABINOID INDUSTRY ESTIMATED AT $2.7 BILLION AND RISING YEARLY COLORADO SPRINGS, Colo., March 18, 2015 /PRNewswire/
EWING, N.J., March 17, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
Breakthrough computer-based drug discovery process enabled drug design of MTH1 inhibitors RESEARCH TRIANGLE PARK, N.C., March 17, 2015 /PRNewswire/ -- Cloud Pharmaceuticals, a therapeutics
LAS VEGAS, March 17, 2015 /PRNewswire/ -- The International Society for CNS Drug Development (ISCDD) announced today that Antony Loebel, M.D., Executive Vice President and Chief Medical Officer
SARASOTA, Fla., March 12, 2015 /PRNewswire/ -- Clinical Update: -- Gained approval of a Clinical Trial Application (CTA) in Europe during January 2015 allowing study of
BIRMINGHAM, Ala., March 11, 2015 /PRNewswire-USNewswire/ -- Southern Research - developer of seven FDA-approved